Gevo, Inc. filings document the company’s renewable-fuels business, Nasdaq-listed common stock, operating results and material corporate events. Form 8-K reports include quarterly and annual financial results, business updates for low-carbon ethanol, carbon management, synthetic aviation fuel initiatives, and material financing or refinancing arrangements involving company subsidiaries.
Proxy and governance filings cover director elections, board composition, auditor ratification, executive compensation votes and officer transitions. The filing record also documents credit agreements, working-capital facilities, renewable natural gas project debt matters, compensatory arrangements and other disclosures related to Gevo’s capital structure, governance and project-development strategy.
Gevo, Inc. officer Andrew Shafer reported a proposed sale of 32,667 common shares, with an approximate sale date of May 27, 2026, and an aggregate market value of $57,487.39. Stifel Nicolaus & Company Inc. is named as the broker. Shafer acquired 67,500 shares through restricted stock awards on May 22, 2024. The notice lists November 19, 2025, as the date of plan adoption or giving of instruction if relying on Rule 10b5-1.
It also lists three sales during the prior three months: 5,550 shares on March 10, 2026, for gross proceeds of $12,245.00; 5,550 shares on April 1, 2026, for $15,027.00; and 5,550 shares on May 1, 2026, for $11,103.00.
Gevo, Inc. officer Ryan Christopher Michael reported a proposed sale of 87,700 common shares, with an aggregate market value of $154,334.46 and an approximate sale date of May 27, 2026. The shares were acquired from the issuer as restricted stock awards on May 22, 2024; the amount acquired is listed as 183,333 shares.
Separate prior-sale entries name Christopher Ryan: 100,000 common shares sold March 30, 2026, for gross proceeds of $275,740.00, and 29,797 shares sold March 31, 2026, for gross proceeds of $88,175.00. The reported plan adoption or giving-of-instruction date is November 19, 2025.
Lindsay Fitzgerald, an officer of Gevo, Inc., reported a proposed sale of 9,754 common shares, with an aggregate market value of $17,165.09 and an approximate sale date of May 27, 2026. The stated Rule 10b5-1 plan adoption date is December 1, 2025. The notice also lists a sale of 20,000 shares on March 12, 2026, for gross proceeds of $50,124.00.
Gevo, Inc. reported the results of its 2026 Annual Meeting of Stockholders, held by live online audio webcast. Shareholders representing 138,653,607 votes, or 57.1% of the outstanding voting power as of the record date, were present, providing a quorum.
Stockholders elected three Class I directors to serve until the 2029 annual meeting, with support levels varying by nominee. They also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 134,681,180 votes for, 3,234,531 against and 737,896 abstentions.
In an advisory, non-binding vote on executive compensation, 46,904,827 votes were cast for, 26,882,820 against and 1,220,612 abstained, with 63,645,348 broker non-votes recorded.
Gevo, Inc. reported that Chief Commercial Officer James Kyle Dean received equity-based compensation. He was granted 133,232 shares of restricted common stock, which vest in three equal annual installments starting on the first anniversary of the grant date, subject to continued service. He also received stock options for 153,937 shares of common stock at an exercise price of $1.64 per share, vesting on the same three-year schedule. After these awards, he directly holds 266,448 shares of common stock and 153,937 stock options.
Gevo, Inc. reported that its General Counsel, David Michael Kettner, received an equity compensation grant. He was awarded 133,232 shares of restricted common stock at no cash cost, increasing his direct common stock holdings to 264,288 shares after the grant.
He also received stock options for 153,937 shares of common stock with an exercise price of $1.64 per share, expiring on May 19, 2036. Both the restricted stock and the options vest in three equal annual installments beginning on the first anniversary of the grant date, as long as he remains in continuous service with the company.